Literature DB >> 1321214

The use of feline herpesvirus and baculovirus as vaccine vectors for the gag and env genes of feline leukaemia virus.

R C Wardley1, P J Berlinski, D R Thomsen, A L Meyer, L E Post.   

Abstract

The env and gag genes from feline leukaemia virus were expressed in a thymidine kinase-negative feline herpes-virus and a baculovirus. Cats were vaccinated with various combinations of these recombinant viruses and 100% protection against feline leukaemia virus challenge was achieved using an immunization schedule which utilized both env and gag products delivered at both a mucosal and systemic site.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1321214     DOI： 10.1099/0022-1317-73-7-1811

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  9 in total

1.  Biosynthesis of glycoproteins E and I of feline herpesvirus: gE-gI interaction is required for intracellular transport.

Authors:  J D Mijnes; L M van der Horst; E van Anken; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

2.  Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

Authors:  L Hanlon; D Argyle; D Bain; L Nicolson; S Dunham; M C Golder; M McDonald; C McGillivray; O Jarrett; J C Neil; D E Onions
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats.

Authors:  N Yokoyama; K Maeda; K Fujita; S Ishiguro; T Sagawa; M Mochizuki; Y Tohya; T Mikami
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats.

Authors:  N Yokoyama; K Maeda; Y Tohya; Y Kawaguchi; Y S Shin; M Ono; S Ishiguro; Y Fujikawa; T Mikami
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL.

Authors:  J Tartaglia; O Jarrett; J C Neil; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 6.  Viral vectors for veterinary vaccines.

Authors:  M Sheppard
Journal:  Adv Vet Med       Date:  1999

Review 7.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

Review 8.  Review of companion animal viral diseases and immunoprophylaxis.

Authors:  J R Patel; J G M Heldens
Journal:  Vaccine       Date:  2008-11-27       Impact factor: 3.641

9.  Development of an efficient bioprocess for poultry vaccines using high-density insect cell culture.

Authors:  W E Bentley; M Y Wang; V Vakharia
Journal:  Ann N Y Acad Sci       Date:  1994-11-30       Impact factor: 5.691
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.